Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Mahamaya Lifesciences Ltd (NSE: MAHALIFE), ISIN INE0U9D01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MAHALIFE last traded at ₹184.65 (+1.99%), with a 52-week range of ₹111.00 to ₹205.05 (as of 23 Sep 2026).
Shareholding as of Mar 2026: promoters 56.35%, FIIs 4.77%, DIIs 2.52%, mutual funds 0.00%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.